Galectin Therapeutics
GALT
1,85 €
Share price
0.46%
Change (1 day)
-6.78%
Change (1 year)
Categories
Galectin Therapeutics (GALT) - Total liabilities
Total liabilities on the balance sheet as of March 2025 : €0.10 Billion
According to Galectin Therapeutics's latest financial reports the company's total liabilities are €0.10 Billion. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Galectin Therapeutics - Total liabilities on balance sheet (from 2001 to 2025)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | €80 M | 60.47% |
| 2022-12-31 | €49.85 M | 43.99% |
| 2021-12-31 | €34.62 M | 687.61% |
| 2020-12-31 | €4.39 M | 71.47% |
| 2019-12-31 | €2.56 M | 39.13% |
| 2018-12-31 | €1.84 M | -25.51% |
| 2017-12-31 | €2.47 M | -31.17% |
| 2016-12-31 | €3.59 M | 188.92% |
| 2015-12-31 | €1.24 M | -11.17% |
| 2014-12-31 | €1.4 M | -22.21% |
| 2013-12-31 | €1.8 M | 44.84% |
| 2012-12-31 | €1.24 M | -27.13% |
| 2011-12-31 | €1.7 M | -71.62% |
| 2010-12-31 | €6 M | 75.62% |
| 2009-12-31 | €3.42 M | 307.86% |
| 2008-12-31 | €0.83 M | -73.97% |
| 2007-12-31 | €3.22 M | -33.39% |
| 2006-12-31 | €4.83 M | 315.38% |
| 2005-12-31 | €1.16 M | 57.24% |
| 2004-12-31 | €0.74 M | 146.76% |
| 2003-12-31 | €0.3 M | -52.93% |
| 2002-12-31 | €0.63 M | 2.29% |
| 2001-12-31 | €0.62 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Mirati Therapeutics MRTX | €0.15 B | 50.46% | 🇺🇸 USA |
 MannKind Corp MNKD | €0.39 B | 284.89% | 🇺🇸 USA |